title: Prolonged pustular eruption from hydroxychloroquine: an unusual case of acute generalized exanthematous pustulosis.
abstract: Acute generalized exanthematous pustulosis (AGEP) is a rare cutaneous eruption that often is a reaction to medications, most commonly antibiotics. Clinically, AGEP closely mimics pustular psoriasis and also is similar to subcorneal pustular dermatosis and IgA pemphigus. For clinicians, it is important to differentiate AGEP from pustular psoriasis. Acute generalized exanthematous pustulosis will have an acute drug association. Few cases have been known to be caused by hydroxychloroquine (HCQ). Proper therapeutic management of AGEP includes withdrawal of the offending agent, and resolution typically occurs within 15 days. We report a case of AGEP after HCQ administration that did not follow the usual course of resolution after medication cessation. The patient continued to experience cutaneous eruptions that waxed and waned for 81 days. Hydroxychloroquine has a particularly long half-life and is a known cause of AGEP; therefore, it is possible that HCQ-induced AGEP may not follow the typical rapid recovery time.
authors.affiliation: University of North Carolina, Chapel Hill, USA.
authors.forename: Kelly C
authors.initials: KC
authors.lastname: Pearson
authors.affiliation: University of North Carolina, Chapel Hill, USA.
authors.forename: Dean S
authors.initials: DS
authors.lastname: Morrell
authors.affiliation: University of North Carolina, Chapel Hill, USA.
authors.forename: Susan R
authors.initials: SR
authors.lastname: Runge
authors.affiliation: University of North Carolina, Chapel Hill, USA.
authors.forename: Puneet
authors.initials: P
authors.lastname: Jolly
mesh_terms: D056150:Acute Generalized Exanthematous Pustulosis / Q000175:diagnosis / Q000209:etiology* / Q000473:pathology; D018501:Antirheumatic Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000493:pharmacokinetics; D005260:Female; D006207:Half-Life; D006801:Humans; D006886:Hydroxychloroquine / Q000008:administration & dosage / Q000009:adverse effects* / Q000493:pharmacokinetics; D008875:Middle Aged; D013997:Time Factors
chemical_list: D018501:Antirheumatic Agents; D006886:Hydroxychloroquine